Henlez
Henlez provides biologic solutions to manage recurrent and follicular skin disorders.
Henlez is active in the biopharma, biotechnology, test and measurement space based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2019.
Its activity falls under biopharma, biotechnology, test and measurement; the profile below is assembled from public directory data.
The business is associated with European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
Directory data places it at the Seed stage.
The company reports a headcount in the c_00001_00010 range.
Total disclosed funding stands at about $1M.
| Sector | Biopharma, Biotechnology, Test and Measurement |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2019 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $1,000,000 |
Website: www.henlez.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account